C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/20/2011	US20110258728 Soybean Cultivar S100004
10/20/2011	US20110258727 Soybean Cultivar 98179010
10/20/2011	US20110258723 Soybean Cultivar S090254
10/20/2011	US20110258722 Soybean Cultivar 88211855
10/20/2011	US20110258721 Soybean cultivar s090251
10/20/2011	US20110258720 Soybean Cultivar 81180925
10/20/2011	US20110258719 Soybean Cultivar 1000680
10/20/2011	US20110258718 Soybean Cultivar 85392905
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110258712 Myostatin isoform
10/20/2011	US20110257377 Covalently linked complexes of HIV TAT and ENV PROTEINS
10/20/2011	US20110257376 Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo
10/20/2011	US20110257374 Novel Reagents for Directed Biomarker Signal Amplification
10/20/2011	US20110257367 Allogeneic vaccine and methods to synthesize same
10/20/2011	US20110257366 Method for screening candidate compounds for antitumor drug
10/20/2011	US20110257353 Polymer precursors of radiolabeled compounds, and methods of making and using the same
10/20/2011	US20110257250 Treating Insulin Secreting Cells
10/20/2011	US20110257104 Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor
10/20/2011	US20110257094 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
10/20/2011	US20110257092 Glucagon/glp-1 receptor co-agonists
10/20/2011	US20110257091 Insulin analogs
10/20/2011	US20110257086 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
10/20/2011	US20110257084 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same
10/20/2011	US20110257083 Msp-1 protein preparations from plasmodium
10/20/2011	US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011	US20110257076 Amide based insulin prodrugs
10/20/2011	US20110257036 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof
10/20/2011	US20110257027 Gamma-secretase substrate and methods of use
10/20/2011	US20110256620 Nucleic acid encoding a self-assembling split-fluorescent protein system
10/20/2011	US20110256571 Proteins
10/20/2011	US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex
10/20/2011	US20110256558 Measuring levels of fibrocystin-l
10/20/2011	US20110256554 Methods for predicting pregnancy outcome in a subject by hcg assay
10/20/2011	US20110256544 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
10/20/2011	US20110256543 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
10/20/2011	US20110256525 Compositions and methods for purifying and crystallizing molecules of interest
10/20/2011	US20110256303 Process for crosslinking proteins with dihydroxyacetone
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256178 Borrellia burgdorferi bacterin
10/20/2011	US20110256173 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256165 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256114 T-cell receptor and nucleic acid encoding the receptor
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256094 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
10/20/2011	US20110256088 Targeted delivery of nucleic acids
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256058 Novel Peptides and Uses Thereof
10/20/2011	US20110253984 Electronic grade silk solution, otft and mim capacitor with silk protein as insulating material and methods for manufacturing the same
10/20/2011	CA2796306A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	CA2796303A1 Robo1-fc fusion protein and use thereof for treating tumours
10/20/2011	CA2796248A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	CA2796010A1 Trail r2-specific multimeric scaffolds
10/20/2011	CA2795806A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
10/20/2011	CA2795541A1 Methods and combination
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	CA2793451A1 Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders
10/19/2011	EP2377946A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
10/19/2011	EP2377939A2 Transgenic plant-based methods for plant pests using RNAi
10/19/2011	EP2377937A1 Plants with reduced expression of a CLE-like gene having enhanced yield-related traits and a method for making the same
10/19/2011	EP2377929A1 Thermostable viral polymerases and methods of use
10/19/2011	EP2377922A2 PDX1 expressing endoderm
10/19/2011	EP2377888A1 Fusion protein
10/19/2011	EP2377884A1 Neuritogenic peptides
10/19/2011	EP2377883A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
10/19/2011	EP2377882A1 Peripherally delivered glutamatic acid decarboxylase gene therapy for spinal cord injury pain
10/19/2011	EP2377881A2 Clostridial toxin activatable clostridial toxins
10/19/2011	EP2377880A2 Combination therapy of HIV fusion entry inhibitors targeting gp41
10/19/2011	EP2377879A1 N-terminal HPV E7 fusion proteins
10/19/2011	EP2377878A1 Potent compstatin analogs
10/19/2011	EP2377877A1 Potent compstatin analogs
10/19/2011	EP2377876A1 Use of proteins and peptides of the TGF-BETA superfamily for purification and therapeutic methods
10/19/2011	EP2377549A1 Use of IL-21 for treating viral infections
10/19/2011	EP2377548A2 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
10/19/2011	EP2377547A1 Use of IL-21 as an antimicrobial agent
10/19/2011	EP2377546A2 Compositions and methods for promoting wound healing and tissue regeneration
10/19/2011	EP2376654A2 Vaccines targeting cellular death receptors
10/19/2011	EP2376643A1 Method for producing beta-santalene
10/19/2011	EP2376636A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt9 polypeptides
10/19/2011	EP2376632A1 Compositions, methods and related uses for cleaving modified dna
10/19/2011	EP2376532A2 Organic compounds
10/19/2011	EP2376531A1 Novel insulin analogues
10/19/2011	EP2376530A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376529A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376528A1 Peptides and compositions for prevention of cell adhesion and methods of using same
10/19/2011	EP2376527A1 Polypeptides having lipase activity and polynucleotides encoding same
10/19/2011	EP2376526A1 Modified streptococcus pneumoniae pneumolysin (ply) polypeptides
10/19/2011	EP2376525A2 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
10/19/2011	EP2376520A1 Insulin analogs
10/19/2011	EP2376111A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/19/2011	EP2376090A1 Inhibition of apoe cleavage activity in the treatment of apoe-related disorders
10/19/2011	EP1989306B1 Plant egg cell transcriptional control sequences
10/19/2011	EP1924601B1 Expression of proteins in e.coli

1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 2916